[Form 4] WORTHINGTON ENTERPRISES, INC. Insider Trading Activity

Rhea-AI Filing Summary

Brantley J. Standridge, a director of Worthington Enterprises, Inc. (WOR), received a grant of 2,815 restricted common shares under the company's 2025 Equity Plan for Non-Employee Directors on 09/25/2025. The shares carry a $0.00 purchase price and will vest on the earlier of the first anniversary of the grant or the date of the company’s next annual shareholders meeting. After the grant, Standridge beneficially owns 4,465 common shares. The Form 4 was signed by an attorney-in-fact on behalf of Standridge on 09/26/2025.

Insights

Corporate Governance Expert

TL;DR: A routine director equity grant aligns a board member with shareholders without indicating material governance change.

The award of 2,815 restricted shares to a non-employee director is a customary compensation mechanism to link director incentives to shareholder value. Vesting tied to the earlier of one year or the next annual meeting is standard and supports retention over the near term. The grant appears to be part of the 2025 Equity Plan and does not, by itself, signal a change in board composition, control, or corporate governance policy.

Securities Analyst

TL;DR: This Form 4 shows a non-cash restricted stock grant with minimal immediate market impact.

The transaction is a non-derivative grant at $0.00 reflecting compensation rather than open-market purchase or sale. Post-grant beneficial ownership of 4,465 shares is disclosed, enabling investors to track insider alignment. There is no exercise price, disposal, or sale reported, and no derivative positions were disclosed, suggesting limited near-term impact on outstanding share count or liquidity.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Standridge Brantley J

(Last) (First) (Middle)

200 W. OLD WILSON BRIDGE RD

(Street)

COLUMBUS OH 43085

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
WORTHINGTON ENTERPRISES, INC. [ WOR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
09/25/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	09/25/2025		A		2,815(1)	A	$0.00	4,465	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. An award of restricted stock was granted pursuant to the Worthington Enterprises, Inc. 2025 Equity Plan for Non-Employee Directors. The restricted stock will vest on the earlier to occur of (1) the first anniversary of the grant date; or (2) the date on which the next Annual Meeting of Shareholders of Worthington Enterprises, Inc. is held.

	/s/Patrick J. Kennedy, as attorney-in fact for Brantley J. Standridge	09/26/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many shares did Brantley Standridge receive in the Form 4 filed for WOR?

The Form 4 reports a grant of 2,815 restricted common shares to Brantley J. Standridge.

What is the vesting schedule for the restricted shares awarded to the director?

The restricted shares vest on the earlier of the first anniversary of the grant date or the date of the companys next Annual Meeting of Shareholders.

What was Standridges beneficial ownership after the reported transaction?

Following the grant, the Form 4 shows total beneficial ownership of 4,465 common shares.

Was there any cash paid for the granted shares?

No. The transaction lists a price of $0.00, indicating the shares were granted as compensation.

When was the transaction and when was the Form 4 signed?

The transaction date is 09/25/2025, and the Form 4 was signed by attorney-in-fact on 09/26/2025.